Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section with Chiba; removed HHS Vulnerability Disclosure and Chiba Locations; page revision updated to v3.3.3.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No core content or study details were modified.SummaryDifference0.1%

- Check39 days agoChange DetectedThe warning banner about potential data updates due to a lapse in government funding was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedTwo screenshots show the same study details with no changes to core content (status, enrollment, outcomes, or eligibility); any differences are limited to formatting and UI tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedMajor update: operating-status notice added and version bumped to v3.2.0; previous version tag v3.1.0 removed.”SummaryDifference4%

- Check89 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.